MapLight Therapeutics (MPLT) Metrics: History & Chart

MapLight Therapeutics, Inc.(MPLT)

Biotechnology · Redwood City, CA

$9.35+0.07 (+0.81%)

Delayed quote: Oct 6, 2026, 12:55 PM EDT

About MapLight Therapeutics, Inc.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis. Additionally, the company is investigating ML-004 for its potential to alleviate social communication deficits and irritability associated with autism spectrum disorder, while ML-021 is designed to target motor impairments seen in Parkinson's disease. Furthermore, ML-009, a G-protein-coupled receptor 52 positive allosteric modulator, is under development for conditions involving hyperactivity, impulsivity, and agitation. Beyond its drug portfolio, MapLight has also established a proprietary platform focused on identifying neural circuits fundamentally linked to disease and then precisely modulating these circuits for therapeutic benefit. Established in 2018 under its former name, Alvarado Therapeutics, Inc., the company adopted the MapLight Therapeutics, Inc. identity in August 2019. Based in Redwood City, California, it operates as a subsidiary of Catalyst4, Inc.

Redwood City, CA

133 employees

www.maplightrx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Christopher A. Kroeger

View full financials

Third-Party DCF Estimate (FMP)	$0.93
Price Gap vs Third-Party Estimate	-89.86%

7D Total Return	-11.20%
30D Total Return	-32.61%
YTD Total Return	-47.18%
1Y Total Return	N/A
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-47.18%
2025	N/A
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

MPLT Valuation Metrics

MPLT Stock Price Metrics

MPLT Dividend Metrics

MPLT Growth Rate Metrics

MPLT Discounted Cash Flow Metrics

MPLT Returns By Period

MPLT Yearly Returns

MPLT Average Annual Returns By Period (CAGR)

MPLT Revenue Metrics

MPLT PE Ratio Metrics

MPLT PS Ratio Metrics

MPLT PB Ratio Metrics

MPLT Price to Free Cash Flow Ratio Metrics

MPLT Debt to Equity Ratio Metrics

MPLT PEG Ratio Metrics

MPLT FCF Yield

MPLT Earnings Yield

MPLT EBITDA Yield

MPLT OCF Yield

MPLT EV/EBIT Ratio Metrics

MPLT EV/EBITDA Ratio Metrics

MPLT EV/Assets Ratio Metrics

MPLT EV/Sales Ratio Metrics

MPLT Current Ratio Metrics

MPLT Quick Ratio Metrics

MPLT ROIC Metrics

MPLT Return on Assets Metrics

MPLT Return on Equity Metrics

MPLT Net Profit Margin Metrics

MPLT Gross Profit Margin Metrics

MPLT Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	1.21
PB Ratio Avg TTM	2.57
PB Ratio Avg 3Y	2.57
Current VS TTM Avg	-52.89%
Current VS 3Y Avg	-52.89%
Current VS 5Y Avg	-52.89%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.01
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.03
Current VS TTM Avg	-81.64%
Current VS 3Y Avg	-81.88%
Current VS 5Y Avg	-80.07%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.96
Ev/Assets Ratio Avg TTM	2.58
Ev/Assets Ratio Avg 3Y	2.58
Current VS TTM Avg	-62.77%
Current VS 3Y Avg	-62.77%
Current VS 5Y Avg	-62.77%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	16.52
Current Ratio Avg TTM	15.51
Current Ratio Avg 3Y	10.50
Current VS TTM Avg	+6.54%
Current VS 3Y Avg	+57.31%
Current VS 5Y Avg	+73.04%

Quick Ratio	16.52
Quick Ratio Avg TTM	15.51
Quick Ratio Avg 3Y	10.50
Current VS TTM Avg	+6.54%
Current VS 3Y Avg	+57.31%
Current VS 5Y Avg	+73.04%

ROIC	(69.35%)
ROIC Avg 3Y	(71.32%)
ROIC Avg 5Y	(71.32%)
Current VS 3Y Avg	+2.76%
Current VS 5Y Avg	+2.76%
Current VS 10Y Avg	+2.76%

ROA	(62.39%)
ROA Avg TTM	(18.87%)
ROA Avg 3Y	(13.97%)
Current VS TTM Avg	-230.68%
Current VS 3Y Avg	-346.61%
Current VS 5Y Avg	-391.27%

ROE	(65.99%)
ROE Avg TTM	(68.01%)
ROE Avg 3Y	(70.64%)
Current VS TTM Avg	+2.97%
Current VS 3Y Avg	+6.58%
Current VS 5Y Avg	+6.58%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A